FDA Inspection 1264020 — Carter BloodCare - Tyler
The FDA completed an inspection of Carter BloodCare - Tyler on March 7, 2025 in Tyler, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tyler, TX (United States)